المؤلفون: Pardeep S. Jhund, Su E. Yeoh, Dirk J. van Veldhuisen, Bertram Pitt, Karl Swedberg, John J.V. McMurray, João Pedro Ferreira, Faiez Zannad, Matteo Serenelli, Pooja Dewan

المساهمون: Cardiovascular Centre (CVC)

المصدر: European Journal of Heart Failure, 24(3), 529-538. Wiley

مصطلحات موضوعية: Male, medicine.medical_specialty, COPD, Ejection fraction, business.industry, Chronic obstructive pulmonary disease, Hazard ratio, Stroke Volume, Heart failure, medicine.disease, Placebo, Sudden death, Confidence interval, Mineralocorticoid receptor antagonists, respiratory tract diseases, Pulmonary Disease, Chronic Obstructive, Internal medicine, Cardiology, medicine, Clinical endpoint, Humans, Cardiology and Cardiovascular Medicine, business, Respiratory Sounds

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::688aa2871b2b968d73eff4f1a160228aTest
https://research.rug.nl/en/publications/43848bda-6ed6-4b6b-b97e-dc197c3a7eecTest

المؤلفون: Faiez Zannad, João Pedro Ferreira, Marc A. Pfeffer, Brian Claggett, Jiankang Liu, Scott D. Solomon, Orly Vardeny, Bertram Pitt

المصدر: European Journal of Heart Failure. 24:378-384

مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, medicine.medical_treatment, chemistry.chemical_compound, Internal medicine, Outpatients, medicine, Humans, Diuretics, Mineralocorticoid Receptor Antagonists, Heart Failure, Ejection fraction, Proportional hazards model, business.industry, Hazard ratio, Stroke Volume, Loop diuretic, medicine.disease, Hospitalization, chemistry, Heart failure, Cardiology, Spironolactone, Diuretic, Cardiology and Cardiovascular Medicine, business, Heart failure with preserved ejection fraction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6062ca19f468ae75c2b6f7b639269dTest
https://doi.org/10.1002/ejhf.2376Test

المؤلفون: Stuart J. Pocock, Daniel Cotton, Martina Brueckmann, Stefan D. Anker, James L. Januzzi, Gerasimos Filippatos, Waheed Jamal, Milton Packer, João Pedro Ferreira, Javed Butler, Tomoko Iwata, Faiez Zannad

المساهمون: BOZEC, Erwan, Baylor Heart and Vascular Institute, Baylor University Medical Center, Imperial College London, Division of Cardiology, Harvard Medical School and Massachusetts General Hospital, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Department of Medicine, University of Mississippi School of Medicine, National and Kapodistrian University of Athens (NKUA), Department of Medical Statistics, London School of Hygiene and Tropical Medicine, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim, Eli Lilly and Company.

المصدر: European Journal of Heart Failure
European Journal of Heart Failure, European Society of Cardiology (Wiley), 2021, 23 (9), pp.1529-1538. ⟨10.1002/ejhf.2256⟩

مصطلحات موضوعية: medicine.medical_specialty, New York Heart Association Class, Empagliflozin, Renal function, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Glucosides, Troponin T, Diabetes mellitus, Internal medicine, medicine, Sodium-glucose co-transporter 2 inhibition, Humans, Benzhydryl Compounds, Heart Failure, Ejection fraction, biology, business.industry, Stroke Volume, Atrial fibrillation, Prognosis, medicine.disease, Troponin, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Heart failure, Cardiology, biology.protein, Cardiology and Cardiovascular Medicine, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d7d06292ba1b4e6819c2c2708d9739Test
https://doi.org/10.1002/ejhf.2256Test

المؤلفون: Nilesh J. Samani, João Pedro Ferreira, Kenneth Dickstein, Faiez Zannad, Sven Meyer, Marco Metra, John R. Teerlink, Carlo Lombardi, Chim C. Lang, Alice Ravera, Adriaan A. Voors, Iziah E Sama, Bernadet T. Santema, Valentina Carubelli, Stefan D. Anker, Dirk J. van Veldhuisen

المساهمون: University Medical Center Groningen [Groningen] (UMCG), Azienda Socio Sanitaria Territoriale Spedali Civili di Brescia [Brescia], Università degli Studi di Brescia = University of Brescia (UniBs), Carl Von Ossietzky Universität Oldenburg = Carl von Ossietzky University of Oldenburg (OFFIS), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), University of Dundee, Ninewells Hospital and Medical School [Dundee], University of Bergen (UiB), Stavanger University Hospital, Berlin-Brandenburg Center for Regenerative Medicine [Berlin, Germany] (BCRT), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, University of California [San Francisco] (UC San Francisco), University of California (UC), Veterans Affairs Medical Center, San Francisco, California, European Project: 242209,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,BIOSTAT-CHF(2010), Cardiovascular Centre (CVC), BOZEC, Erwan, A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure - BIOSTAT-CHF - - EC:FP7:HEALTH2010-04-01 - 2015-03-31 - 242209 - VALID, Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Heart Center Oldenburg, Department of Cardiology, European Medical School Oldenburg-Groningen, Carl von Ossietzky University Oldenburg, Department of Cardiovascular Sciences, University of Leicester, NIHR (National Institute for Health Research) Leicester Biomedical Research Centre, Glenfield Hospital

المصدر: European Journal of Heart Failure
European Journal of Heart Failure, 2021, 23 (4), pp.567-577. ⟨10.1002/ejhf.2154⟩
European Journal of Heart Failure, 23(4), 567-577. Wiley

مصطلحات موضوعية: Male, medicine.medical_specialty, 030204 cardiovascular system & hematology, Heart failure, Outcome, Quality of life, Sex, Women, Female, Humans, Kansas, Quality of Life, Stroke Volume, Surveys and Questionnaires, Cardiomyopathies, Heart Failure, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Medicine, Ejection fraction, business.industry, medicine.disease, Tailored treatment, humanities, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Clinical trial, Kansas City Cardiomyopathy Questionnaire, Cardiology and Cardiovascular Medicine, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41a0899f3589d228b85395342e2e3d9Test
https://doi.org/10.1002/ejhf.2154Test

المؤلفون: Afshin Salsali, João Pedro Ferreira, Mitchell A. Psotka, Martina Brueckmann, Mikhail Kosiborod, Jan Biegus, Adriaan A. Voors, Claudia Grauer, Christiane E. Angermann, John R. Teerlink, Jon Blatchford, Sean P. Collins, Piotr Ponikowski, Michael E. Nassif, Jasper Tromp

المساهمون: Cardiovascular Centre (CVC), University Medical Center Groningen [Groningen] (UMCG), Duke-NUS Medical School [Singapore], National Heart Centre Singapore (NHCS), University of Wrocław [Poland] (UWr), Boehringer Ingelheim Pharma GmbH & Co. KG, Rutgers, The State University of New Jersey [New Brunswick] (RU), Rutgers University System (Rutgers), University Hospital of Würzburg, Boehringer Ingelheim International GmbH, Vanderbilt University Medical Center [Nashville], Vanderbilt University [Nashville], Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Saint Luke's Mid America Heart Institute, University of New South Wales [Sydney] (UNSW), Inova Heart and Vascular Institute, Falls Church, Medizinische Fakultät Mannheim, University of California [San Francisco] (UCSF), University of California, Veterans Affairs Medical Center, San Francisco, California, The EMPULSE trial is funded by the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance.

المصدر: European Journal of Heart Failure, 23(5), 826-834. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2021, ⟨10.1002/ejhf.2137⟩

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, Trial design, medicine.medical_specialty, Asia, Acute decompensated heart failure, Heart failure, 030204 cardiovascular system & hematology, Placebo, Sodium–glucose co‐transporter 2 inhibitors, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Sodium-Glucose Transporter 2, glucose co‐, Diabetes mellitus, Internal medicine, Empagliflozin, medicine, Humans, In patient, Sodium–, Study Design, Ejection fraction, business.industry, Sodium, Stroke Volume, medicine.disease, 3. Good health, Europe, Glucose, Kansas City Cardiomyopathy Questionnaire, North America, Cardiology and Cardiovascular Medicine, business, transporter 2 inhibitors

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8002ded798854384daa4260943d936eaTest
https://doi.org/10.1002/ejhf.2137Test

المؤلفون: Michael R. Zile, Akshay S. Desai, Brian Claggett, Lars Køber, Orly Vardeny, Faiez Zannad, Martin Lefkowitz, Inder S. Anand, Victor Shi, Dirk J. van Veldhuisen, John G.F. Cleland, Milton Packer, João Pedro Ferreira, John J.V. McMurray, Marc A. Pfeffer, Sanjiv J. Shah, Scott D. Solomon, Jean L. Rouleau, Jiankang Liu

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), British Heart Foundation Glasgow Cardiovascular Research Centre (BHF GCRC), University of Glasgow-NHS Greater Glasgow and Clyde, Brigham & Women’s Hospital [Boston] (BWH), Harvard Medical School [Boston] (HMS), University of Minnesota [Twin Cities] (UMN), University of Minnesota System, University Medical Center Groningen [Groningen] (UMCG), Rigshospitalet [Copenhagen], Copenhagen University Hospital, University of Glasgow, Montreal Heart Institute - Institut de Cardiologie de Montréal, Imperial College London, Baylor University, University of South California (USC), Neuroimaging group, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, Northwestern University Feinberg School of Medicine, Minneapolis VA Center for Care Delivery and Outcomes Research, University of Minnesota, J.P.F. is funded by an ESC research grant for collaboration with the University of Glasgow. All other authors report no specific funding for this project. J.J.V.McM. and P.S.J. are supported by a British Heart Foundation Centre of Research Excellence Grant RE/18/6/34217., BOZEC, Erwan, University of Southern California (USC), Novartis Pharmaceuticals Corporation [East Hanover, NJ], Cardiovascular Centre (CVC)

المصدر: Ferreira, J P, Claggett, B L, Liu, J, Desai, A S, Pfeffer, M A, Anand, I S, van Veldhuisen, D J, Kober, L, Cleland, J G F, Rouleau, J L, Packer, M, Zile, M R, Shi, V C, Lefkowitz, M P, Shah, S J, Vardeny, O, Zannad, F, Solomon, S D & McMurray, J J V 2021, ' Serum potassium and outcomes in heart failure with preserved ejection fraction : a post-hoc analysis of the PARAGON-HF trial ', European Journal of Heart Failure, vol. 23, no. 5, pp. 776-784 . https://doi.org/10.1002/ejhf.2134Test
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2021, ⟨10.1002/ejhf.2134⟩
European Journal of Heart Failure, 2021, ⟨10.1002/ejhf.2134⟩
European Journal of Heart Failure, 23(5), 776-784. Wiley

مصطلحات موضوعية: medicine.medical_specialty, Outcomes, 030204 cardiovascular system & hematology, valsartan, Sacubitril, Angiotensin Receptor Antagonists, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, medicine, Humans, Sacubitril/valsartan, Aged, Cause of death, Heart Failure, Ejection fraction, business.industry, Aminobutyrates, Serum potassium, Hazard ratio, Stroke Volume, medicine.disease, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Heart failure with preserved ejection fraction, Valsartan, Heart failure, Potassium, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Sacubitril, Valsartan, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4da8e89429c383f280196584a0932aTest
https://doi.org/10.1002/ejhf.2134Test

المؤلفون: Joseph J Cuthbert, Pierpaolo Pellicori, Johannes Petutschnigg, Franco Cosmi, Blerim Mujaj, João Pedro Ferreira, Fozia Z Ahmed, Nicolas Girerd, Faiez Zannad, Roberto Latini, Timothy Collier, Patrick Rossignol, Beatrice Mariottoni, Jan A. Staessen, John G.F. Cleland, Stephane Heymans, Andrew L. Clark, Job A J Verdonschot, Arantxa González, Hans-Peter Brunner-La Rocca

المساهمون: Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, Robertson Institute of Biostatistics and Clinical Trials Unit, University of Glasgow, Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Cortona Hospital, Department of Cardiology, Maastricht University Medical Center, Manchester Heart Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Sciences Centre, London School of Hygiene and Tropical Medicine (LSHTM), Castle Hill Hospital, Hull York Medical School, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], DZHK (German Center of Cardiovascular Research), Partner Site Berlin, Research Unit Hypertension and Cardiovascular Epidemiology [Louvain, Belgique], Studies Coordinating Centre [Louvain, Belgique], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven)-Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Center for Applied Medical Research [Plamplona] (CIMA), Universidad de Navarra [Pamplona] (UNAV), Queensland University of Technology [Brisbane] (QUT), Maastricht University [Maastricht], Cardiovascular Research Institute [Maastricht], Maastricht University Medical Centre - MUMC [Maastricht, The Netherlands], IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri' [Milan, Italy], Dutch Heart Foundation, CVON2016-Early HFPEF, 2015-10, CVON She-PREDICTS, grant 2017-21, Contrat de plan Etat-lorraine and FEDER lorraine, British Heart Foundation Centre of Research Excellence grant number RE/18/6/34217, ERA-Net-CVD project MacroERA, 01KL1706, IMPACT GEENAGE, ANR-15-IDEX-0004,LUE,Isite LUE(2015), ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), DE CARVALHO, Philippe, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, Heart OMics in AGEing - HOMAGE - - EC:FP7:HEALTH2013-02-01 - 2019-01-31 - 305507 - VALID

المصدر: European journal of heart failure, 22(9), 1711-1723. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure, 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩

مصطلحات موضوعية: Male, Aging, [SDV]Life Sciences [q-bio], ALDOSTERONE ANTAGONISM, 030204 cardiovascular system & hematology, Spironolactone, Ventricular Function, Left, Coronary artery disease, chemistry.chemical_compound, DOUBLE-BLIND, 0302 clinical medicine, Interquartile range, Natriuretic Peptide, Brain, Clinical endpoint, Natriuretic peptide, Prospective Studies, COLLAGEN TURNOVER, Ejection fraction, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Atrial fibrillation, DIASTOLIC DYSFUNCTION, 3. Good health, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, [SDV] Life Sciences [q-bio], PRESERVED EJECTION FRACTION, BRAIN NATRIURETIC PEPTIDE, Cardiology, Female, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, NT-PROBNP, EXTRACELLULAR-MATRIX TURNOVER, medicine.drug_class, BIOMARKERS, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, medicine, Humans, Aged, Heart Failure, business.industry, Stroke Volume, Study design, medicine.disease, Fibrosis, Peptide Fragments, Diabetes Mellitus, Type 2, chemistry, HOMAGE, MYOCARDIAL-INFARCTION, Heart failure, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7ac2c112b2893e48ddb70dd85b1c1eeTest
https://doi.org/10.1002/ejhf.1716Test

المؤلفون: Milton Packer, Karl Swedberg, Michael R. Zile, Jean L. Rouleau, Alice M Jackson, William T. Abraham, Kenneth Dickstein, Scott D. Solomon, Mark C. Petrie, Pooja Dewan, Akshay S. Desai, João Pedro Ferreira, Li Shen, Lars Køber, John J.V. McMurray, Pardeep S. Jhund

المصدر: Dewan, P, Jackson, A, Jhund, P S, Shen, L, Ferreira, J P, Petrie, M C, Abraham, W T, Desai, A S, Dickstein, K, Køber, L, Packer, M, Rouleau, J L, Solomon, S D, Swedberg, K, Zile, M R & McMurray, J J V 2020, ' The prevalence and importance of frailty in heart failure with reduced ejection fraction – an analysis of PARADIGM-HF and ATMOSPHERE ', European Journal of Heart Failure, vol. 22, no. 11, pp. 2123-2133 . https://doi.org/10.1002/ejhf.1832Test

مصطلحات موضوعية: Male, medicine.medical_specialty, Prognostic variable, Outcomes, 030204 cardiovascular system & hematology, Rate ratio, Paradigm hf, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Internal medicine, Prevalence, medicine, Humans, Decompensation, Heart Failure, Ejection fraction, Frailty, business.industry, Hazard ratio, Stroke Volume, Heart failure with reduced ejection fraction, medicine.disease, Hospitalization, Heart failure, Quality of Life, Cardiology, Female, Cardiology and Cardiovascular Medicine, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbea9e569c343fd5f3ffaf39b656456fTest
https://doi.org/10.1002/ejhf.1832Test

المؤلفون: Pardeep S. Jhund, Mark C. Petrie, Nicolas Girerd, Abhinav Sharma, Marc A. Pfeffer, John Gregson, Kieran F. Docherty, Kenneth Dickstein, Faiez Zannad, Patrick Rossignol, John J.V. McMurray, João Pedro Ferreira, Kevin Duarte, Bertram Pitt

المصدر: European Journal of Heart Failure. 22:848-855

مصطلحات موضوعية: medicine.medical_specialty, Myocardial Infarction, 030204 cardiovascular system & hematology, Ventricular Function, Left, Sudden cardiac death, Ventricular Dysfunction, Left, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Humans, cardiovascular diseases, Myocardial infarction, Carvedilol, Aged, Heart Failure, Framingham Risk Score, Ejection fraction, business.industry, Stroke Volume, Atrial fibrillation, medicine.disease, Death, Sudden, Cardiac, Valsartan, Heart failure, Cardiology, Cardiology and Cardiovascular Medicine, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5276ff4a962f80544fd77dcdd3197b5bTest
https://doi.org/10.1002/ejhf.1694Test

المؤلفون: Gerasimos Filippatos, Faiez Zannad, Martina Brueckmann, Cordula Zeller, Emperor Trial Committees, João Pedro Ferreira, Investigators, Waheed Jamal, Milton Packer, Stuart J. Pocock, Stefan D. Anker, Javed Butler

المصدر: European Journal of Heart Failure

مصطلحات موضوعية: medicine.medical_specialty, Renal function, 030204 cardiovascular system & hematology, Sodium–glucose co‐transporter 2 inhibitors, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Internal medicine, Empagliflozin, Clinical endpoint, medicine, Humans, Dapagliflozin, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Randomized Controlled Trials as Topic, Heart Failure, Ejection fraction, Study Design, business.industry, Cardiovascular Agents, Stroke Volume, medicine.disease, Heart failure with reduced ejection fraction, Renal outcomes, Transplantation, Hospitalization, Heart failure with preserved ejection fraction, chemistry, Heart failure, Cardiology and Cardiovascular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbabf8830a5d2deda8f2034e5e5abf40Test
https://pubmed.ncbi.nlm.nih.gov/33251659Test